Northridge-based Gamma Medica-Ideas, a developer of digital molecular imaging systems, said Tuesday that it has raised $24M in financing. The firm said the round, the first institutional funding for the firm, was made up of $14M in equity, $5M in mezzanine debt, and a $5M revolving line of credit. The equity funding came from Psilos Group, along with Capital Resource Partners, which also provided mezzanine debt to the firm. The revolving line of credit came from Bridge Bank. Gamma Medica-Ideas develops digital imaging products, used for medical research and the drug discovery market, as well as for diagnosis of cancer in women.